These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 20209122

  • 1. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N, Craig JE.
    PLoS One; 2010 Mar 01; 5(3):e9462. PubMed ID: 20209122
    [Abstract] [Full Text] [Related]

  • 2. Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes.
    Fogarty RD, Abhary S, Javadiyan S, Kasmeridis N, Petrovsky N, Whiting MJ, Craig JE, Burdon KP.
    J Diabetes Complications; 2012 Mar 01; 26(3):195-8. PubMed ID: 22521321
    [Abstract] [Full Text] [Related]

  • 3. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 01; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 4. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R.
    Nephrol Dial Transplant; 2013 Apr 01; 28(4):964-71. PubMed ID: 23129820
    [Abstract] [Full Text] [Related]

  • 5. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls.
    Brites-Anselmi G, Azevedo AMM, Miyazaki AHL, Pinheiro LC, Coeli-Lacchini FB, de Andrade MF, Molina CAF, Tucci S, Hirsch E, Tanus-Santos JE, Lacchini R.
    Nitric Oxide; 2019 Nov 01; 92():11-17. PubMed ID: 31394201
    [Abstract] [Full Text] [Related]

  • 6. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Nov 01; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 7. Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.
    Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD.
    Atherosclerosis; 2014 Nov 01; 237(1):38-44. PubMed ID: 25194333
    [Abstract] [Full Text] [Related]

  • 8. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
    Amir M, Hassanein SI, Abdel Rahman MF, Gad MZ.
    Mol Biol Rep; 2018 Dec 01; 45(6):2411-2419. PubMed ID: 30284143
    [Abstract] [Full Text] [Related]

  • 9. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, Chen Y.
    Arterioscler Thromb Vasc Biol; 2011 Jul 01; 31(7):1540-6. PubMed ID: 21493890
    [Abstract] [Full Text] [Related]

  • 10. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Atherosclerosis; 2010 Mar 01; 209(1):66-73. PubMed ID: 19775692
    [Abstract] [Full Text] [Related]

  • 11. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
    Lu TM, Lin SJ, Lin MW, Hsu CP, Chung MY.
    Cardiovasc Diabetol; 2011 Feb 09; 10():16. PubMed ID: 21303562
    [Abstract] [Full Text] [Related]

  • 12. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V, Tomandl J, Pácal L, Klepárník M, Malúšková D, Bartáková V, Kuricová K, Rehořová J, Stěpánková S, Svojanovský J, Olšovský J, Bělobrádková J, Krusová D, Jurajda M, Mužík J, Pavlík T, Kaňková K.
    Kidney Blood Press Res; 2012 Feb 09; 36(1):200-8. PubMed ID: 23147199
    [Abstract] [Full Text] [Related]

  • 13. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 14. Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity.
    Lambden S, Tomlinson J, Piper S, Gordon AC, Leiper J.
    Crit Care; 2018 Dec 11; 22(1):336. PubMed ID: 30538005
    [Abstract] [Full Text] [Related]

  • 15. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B, Nandi M, Kelly P, Wojciak-Stothard B, Fleming I, Leiper J.
    Vasc Med; 2010 Jun 11; 15(3):205-13. PubMed ID: 20219849
    [Abstract] [Full Text] [Related]

  • 16. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
    Javadiyan S, Burdon KP, Whiting MJ, Abhary S, Straga T, Hewitt AW, Mills RA, Craig JE.
    Invest Ophthalmol Vis Sci; 2012 Apr 18; 53(4):1923-7. PubMed ID: 22395885
    [Abstract] [Full Text] [Related]

  • 17. Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine.
    Yuan Q, Hu CP, Gong ZC, Bai YP, Liu SY, Li YJ, Jiang JL.
    Biochem Biophys Res Commun; 2015 Mar 20; 458(4):869-76. PubMed ID: 25701782
    [Abstract] [Full Text] [Related]

  • 18. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW, Xiong Y, He P.
    Nitric Oxide; 2007 Feb 20; 16(1):94-103. PubMed ID: 16979918
    [Abstract] [Full Text] [Related]

  • 19. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C, Mowat F, Sayed H, Mehad M, Duluc L, Piper S, Luhmann U, Nandi M, Kelly P, Smith A, Ali R, Leiper J, Bainbridge J.
    Exp Eye Res; 2016 Jun 20; 147():148-155. PubMed ID: 27181226
    [Abstract] [Full Text] [Related]

  • 20. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M, Liu L, Guo Z, Xiong Y.
    Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.